PureTech Health Shares Rise as Investee Seaport Therapeutics Prices Nasdaq IPO
Seaport Therapeutics, a clinical-stage neuropsychiatry company founded by PureTech Health (PRTC), priced its upsized $254.9 million Nasdaq IPO at the top of its target range. This led to an increase in PureTech's share price as investors reacted positively.
Tickers: $PRTC
Topics: biotech clinical-stage company ipo stock price movement